LAS VEGAS, December 8, 2011 /PRNewswire/ --
Life Length®, the world's leading telomere testing and services company, announced an agreement with Age Diagnostic Laboratories, Inc ("ADL") of Boca Raton, Florida to offer its test nationwide. The partnership will centralize the collection of blood and tissue samples to be forwarded to Life Length's lab in Europe for analysis.
Stephen J. Matlin, CEO, Life Length said, "We are delighted to partner with ADL. This is a major step commercializing Life Length's Telomere Analysis Technology in the U.S. making it easy for physicians and their patients to take our biomarker test. Telomeres are best predictors of biological age and excellent general health indicators, highly related to the emergence of age-related diseases. This test will likely become standard in checks-up and preventive healthcare. U.S. Doctors can now incorporate Life Length's telomere test easily into their practice."
Dr. Mark Rosenberg, Medical Director, ADL said, "We are pleased to partner with Life Length which measures each individual telomere with enormous precision. Currently, all other approaches provide imprecise estimates of average telomere length which offer little utility or insight. Life Length's approach has the advantage of measuring the percentage of critically short telomeres, which are responsible for cell senescence and aging. We believe this is very important for the serious anti-aging practitioner."
About Life Length
Life Length, a life sciences company founded in 2010 to commercially exploit Telomere Analysis Technology (TAT) developed by Dr. Maria Blasco, Chief Scientific Advisor, Life Length and Director, Spanish National Cancer Research Centre, provides testing services to pharmaceutical and biotech industries for drug R&D and clinical trials, as well as to the general public through physicians and clinics interested in telomere indicators of biological age and overall health.
|SOURCE Life Length|
Copyright©2010 PR Newswire.
All rights reserved